Press "Enter" to skip to content

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Original source: http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatments-heart-disease-caused-serious-rare-disease-transthyretin-mediated

Also Read:   Coronavirus (COVID-19) Update: Daily Roundup July 14, 2020